One out of every three people living with HIV in Latin America does not know it, mainly because of the stigma that this disease is and that there is no culture of prevention, said Carlos Magis of the National Center of Mexico for the Prevention and Control of HIV / AIDS (Censida).
"There is still a delay in diagnosis despite the fact that today a person who is diagnosed and treated in time has a high life expectancy", said Magis, director of Censida's comprehensive care.
The doctor explained that under current treatments, life expectancy is 40 years in people infected with this virus.
Brenda Krabre Ramirez, local president of the International AIDS Society (AIDS), said this Violence, stigma and injustice for access to prevention and information are the most important obstacles to overcome.
"The fact is, as long as we do not fight it, the AIDS epidemic will not be effectively attacked", he argues.
Experts said that between People who have less discovery are mostly heterosexual men and adults.
"Especially in this last group they are slow to perceive that they are at risk because there is a lot of stigma for this disease", said Juan Sierra, head of the Department of Infectiology at the Mexican Institute of Medical Sciences and Nutrition, Salvador Zubiran.
In Mexico, according to Censida, a little more than 141 000 people are currently in retroviral treatment and since 1996 mortality has decreased, although there are still 5 000 deaths per year for this disease.
"With the treatments we offer at the Ministry of Health, patients have become better 51% of those diagnosed and treated reduce the viral load by six months ""Magis said.
He added that one of the disadvantages of the region is that the pharmaceutical tests are still not available to the population, which in countries like the United States are available to anyone who wants to get a quick test.
He added that reducing the cost of treatment would be very beneficial in countries like Mexico, where The cost of HIV treatment accounts for one-third of the catastrophic costs of Seguro Popular Fund.
"Public policies should focus on improving access to treatment and one of the options is to reduce costs, to make consolidated purchases of medicines and to allow more medication to reach Mexico, "he said.
He explained that in regions like Africa the cost of treatment is $ 100 per year, due to the fact that therapy is based on generic retroviruses; while in Mexico, costs amount to $ 2,000 to be based on patented medicines.
Sierra said that the patient with HIV in Mexico, in addition to stigma and discrimination, he must face an unfriendly health system to follow the treatment.
"Unfortunately, we have a fragmented health system and this is not very useful for people who have illnesses that need to be treated for life. Sometimes institutions are an obstacle to the continuity needed to treat HIV"he said.